Spectral AI Ltd. WKN: A3EQAD ISIN: US84757T1051 Kürzel: MDAI Forum: Aktien User: Solix

Ich werde mal eine Position eröffnen, sieht nach einem Boden aus....

Das Unternehmen, dessen geprüfter Jahresabschluss noch aussteht, rechnet damit, seine Marktprognose zu übertreffen und einen Jahresumsatz von über 28 Millionen US-Dollar zu erzielen – der höchste in seiner Geschichte. Mit einer aktuellen Marktkapitalisierung von etwa 41 Millionen US-Dollar und einem starken Umsatzwachstum von 45 % in den letzten zwölf Monaten

15% pre market🙂‍↔️

Vom Nov https://www.manilatimes.net/2024/11/21/tmt-newswire/globenewswire/spectral-ai-announces-deepview-snapshot-m-moves-forward-with-feedback-from-brookearmy-medical-center-institute-of-surgical-research/2009030

Prädiktive KI für Wundheilung Die proprietäre Optik von DeepView® ist in der Lage, Millionen von multispektralen Datenpunkten aus jedem Rohbild zu extrahieren. Die DeepView AI ist in der Lage, den Vorhersagewert aus dieser Bibliothek von Tausenden von klinischen multispektralen Bildern von Wunden zu extrahieren, um genaue und objektive Vorhersagen des Wundheilungspotenzials zu liefern.

Heute https://www.globenewswire.com/news-release/2024/12/02/2989827/0/en/Spectral-AI-Completes-Truthing-of-Burn-Center-Images-Initiates-Emergency-Department-Image-Review.html

Frag mich was so ein Teil kostet oder ob es die Firma auch als as a service anbietet. The addressable market for DeepView SnapShot® M is vast and growing. The global mobile medical imaging services market is experiencing significant growth, driven by the increasing demand for portable diagnostic solutions across various healthcare settings. In 2023, the market was valued at approximately USD 14.78 billion and is projected to reach USD 18.4 billion by 2030. DeepView SnapShot® M is designed for use in: Military Applications: Enhancing care for service members in combat and field hospitals. Home Healthcare: Supporting remote diagnostics for patients with chronic wounds. Ambulance Services: Improving pre-hospital decision-making in emergency wound care. Outpatient Clinics: Reducing time to treatment with real-time wound assessments.

If the system receives FDA clearance, BARDA could target contract options to procure additional DeepView devices for placement into burn care and ED settings nationwide for immediate availability to physicians. Later contract options also could provide support for ongoing product improvements. In total, the entire contract could enable procurement of up to 200 DeepView devices, to be placed strategically across U.S. EDs and burn centers.

https://www.spectral-ai.com/press-releases/spectral-ai-announces-repricing-of-its-public-warrants/

☺️

😉🌻

**MDAI** is breaking down now but I will give it room to under $3.00 for remaining shares. Make sure you know what you're risking. The dips and pops should keep us green already and we keep it that way. @everyone

**MDAI** $3.34 off $3.0x dips. Scale pops, buy dips. Stay green now. $3.50 clear gives us room to $3.87 then over that is potential explosion. @everyone

👌